BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26274321)

  • 1. The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.
    Wang Y; Chen J; Song W; Wang Y; Chen Y; Nie Y; Ye Z; Hui R
    PLoS One; 2015; 10(8):e0135526. PubMed ID: 26274321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myotrophin gene by pressure overload and stretch.
    Sil P; Gupta S; Young D; Sen S
    Mol Cell Biochem; 2004 Jul; 262(1-2):79-89. PubMed ID: 15532712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and functional significance of myotrophin: a gene with multiple transcripts.
    Adhikary G; Gupta S; Sil P; Saad Y; Sen S
    Gene; 2005 Jun; 353(1):31-40. PubMed ID: 15946807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy.
    Gupta S; Sen S
    Biochim Biophys Acta; 2002 May; 1589(3):247-60. PubMed ID: 12031792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension.
    Wang X; Yang X; Sun K; Chen J; Song X; Wang H; Liu Z; Wang C; Zhang C; Hui R
    Clin Sci (Lond); 2009 Oct; 118(2):137-45. PubMed ID: 19505289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice.
    Sarkar S; Leaman DW; Gupta S; Sil P; Young D; Morehead A; Mukherjee D; Ratliff N; Sun Y; Rayborn M; Hollyfield J; Sen S
    J Biol Chem; 2004 May; 279(19):20422-34. PubMed ID: 14970239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy.
    Gupta S; Maitra R; Young D; Gupta A; Sen S
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H627-36. PubMed ID: 19502558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth. Regulation by myotrophin hairpin loops.
    Das B; Gupta S; Vasanji A; Xu Z; Misra S; Sen S
    J Biol Chem; 2008 Oct; 283(41):27947-27956. PubMed ID: 18693253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy.
    Anderson KM; Berrebi-Bertrand I; Kirkpatrick RB; McQueney MS; Underwood DC; Rouanet S; Chabot-Fletcher M
    J Mol Cell Cardiol; 1999 Apr; 31(4):705-19. PubMed ID: 10329199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy.
    Knuefermann P; Shi SP; Chen P; Sakata Y; Baumgarten G; Sivasubramanian N
    Tex Heart Inst J; 2006; 33(3):281-9. PubMed ID: 17041682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of HIF1A gene polymorphisms and primary hypertensive left ventricular hypertrophy in Chinese Han population.
    Sheng ZL; Ju CW; Yan GL; Chen ZP; Pan XD; Lu WB; Yao YY; Ma GS
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8095-8100. PubMed ID: 31599436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension.
    Nakagami H; Kikuchi Y; Katsuya T; Morishita R; Akasaka H; Saitoh S; Rakugi H; Kaneda Y; Shimamoto K; Ogihara T
    Hypertens Res; 2007 Dec; 30(12):1239-46. PubMed ID: 18344630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-29b and miRNA-497 Modulate the Expression of Carboxypeptidase X Member 2, a Candidate Gene Associated with Left Ventricular Hypertrophy.
    Subrova J; Böhme K; Gillespie A; Orphal M; Plum C; Kreutz R; Eisenreich A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.
    PLOS ONE Staff
    PLoS One; 2016; 11(1):e0146735. PubMed ID: 26731400
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
    Gupta S; Purcell NH; Lin A; Sen S
    J Cell Biol; 2002 Dec; 159(6):1019-28. PubMed ID: 12486112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased protein kinase C activity in myotrophin-induced myocyte growth.
    Sil P; Kandaswamy V; Sen S
    Circ Res; 1998 Jun; 82(11):1173-88. PubMed ID: 9633917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human ATF1 rs11169571 polymorphism increases essential hypertension risk through modifying miRNA binding.
    Yang S; Gao Y; Liu G; Li J; Shi K; Du B; Si D; Yang P
    FEBS Lett; 2015 Jul; 589(16):2087-93. PubMed ID: 26149214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare SNP rs12731181 in the miR-590-3p Target Site of the Prostaglandin F2α Receptor Gene Confers Risk for Essential Hypertension in the Han Chinese Population.
    Xiao B; Gu SM; Li MJ; Li J; Tao B; Wang Y; Wang Y; Zuo S; Shen Y; Yu Y; Chen D; Chen G; Kong D; Tang J; Liu Q; Chen DR; Liu Y; Alberti S; Dovizio M; Landolfi R; Mucci L; Miao PZ; Gao P; Zhu DL; Wang J; Li B; Patrignani P; Yu Y
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1687-95. PubMed ID: 25977569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
    Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
    Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension.
    Kontaraki JE; Marketou ME; Parthenakis FI; Maragkoudakis S; Zacharis EA; Petousis S; Kochiadakis GE; Vardas PE
    J Am Soc Hypertens; 2015 Oct; 9(10):802-810. PubMed ID: 26358152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.